Rangering i aksjer
#28091
HeraMED Limited and its associated entities are dedicated to the design,... HeraMED Limited and its associated entities are dedicated to the design, production, and sale of at-home fetal heart rate monitors and comprehensive pregnancy monitoring systems. These solutions are offered to consumers throughout Australia, Europe, and Israel. Key products include HeraBEAT, a device enabling expectant mothers to personally track their baby's heartbeat, and HeraCARE, a sophisticated digital platform facilitating the creation and deployment of health solutions for effective maternity care management. The company is also at the forefront of developing EchoBEAT, envisioned as the subsequent evolution of its domestic pregnancy monitoring tools, alongside Orion, an artificial intelligence-driven system engineered for profound pregnancy monitoring analysis. A strategic partnership with Mayo Clinic supports the ongoing advancement of the HeraCARE pregnancy management platform. Established in 2011, HeraMED Limited operates from its main office in Netanya, Israel.
Handel HeraMED Limited (HMD)
Pris HMD pris med markedsverdi på B
Markedsverdi av HeraMED Limited(HMD)
Markedsverdi: $28.60M
Per August 2026 har HeraMED Limited en markedsverdi på $28.60M. Dette gjør HeraMED Limited til det 28091st mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for HeraMED Limited fra 2018 til 2026
HMD sammenlignet med topp 5 mest populære stocks
| Pris på HMD |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.301T
|
+18,532,557.18%
|
|
|
|
|
$4.634T
|
+16,200,622.01%
|
|
|
|
|
$4.143T
|
+14,484,403.83%
|
|
|
|
|
$3.589T
|
+12,548,904.24%
|
|
|
|
|
$2.857T
|
+9,988,235.83%
|
